Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge
- PMID: 10191238
- DOI: 10.1086/314732
Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge
Abstract
Two groups of human volunteers were inoculated with 2 doses of live Haemophilus ducreyi 35000HP. The reinfection group consisted of 7 subjects who previously had participated in experimental infection with 35000HP to the pustular stage of disease. The control group consisted of 7 naive subjects. Papules developed at 92.8% (95% confidence interval [CI], 66.1%-99.8%) of sites inoculated with live bacteria, in the reinfection group, and at 85.7% (95% CI, 57.2%-98. 2%) of sites in the control group. Sixty-nine percent (95% CI, 36. 8%-90.9%) of papules evolved into pustules in the reinfection group, compared with 41% (95% CI, 15.2%-72.3%) in the control group. The recovery rates of H. ducreyi from surface cultures and the histopathology of biopsies obtained from both groups were similar. Thus, experimental infection to the pustular stage of disease does not provide protective immunity against subsequent challenge.
Similar articles
-
Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid.J Immunol. 1994 Jan 1;152(1):184-92. J Immunol. 1994. PMID: 8254191
-
Standardization of the experimental model of Haemophilus ducreyi infection in human subjects.J Infect Dis. 1998 Dec;178(6):1684-7. doi: 10.1086/314483. J Infect Dis. 1998. PMID: 9815220
-
A DltA mutant of Haemophilus ducreyi Is partially attenuated in its ability to cause pustules in human volunteers.Infect Immun. 2006 Feb;74(2):1394-7. doi: 10.1128/IAI.74.2.1394-1397.2006. Infect Immun. 2006. PMID: 16428791 Free PMC article.
-
Interactions of the Skin Pathogen Haemophilus ducreyi With the Human Host.Front Immunol. 2021 Feb 3;11:615402. doi: 10.3389/fimmu.2020.615402. eCollection 2020. Front Immunol. 2021. PMID: 33613541 Free PMC article. Review.
-
Haemophilus ducreyi: pathogenesis and protective immunity.Trends Microbiol. 1995 Mar;3(3):87-92. doi: 10.1016/s0966-842x(00)88888-5. Trends Microbiol. 1995. PMID: 7773593 Review.
Cited by
-
Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers.J Infect Dis. 2010 Jun 15;201(12):1839-48. doi: 10.1086/652781. J Infect Dis. 2010. PMID: 20443736 Free PMC article.
-
Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.Infect Immun. 2003 Nov;71(11):6658-63. doi: 10.1128/IAI.71.11.6658-6663.2003. Infect Immun. 2003. PMID: 14573692 Free PMC article.
-
Immunopathogenesis of Haemophilus ducreyi infection (chancroid).Infect Immun. 2002 Apr;70(4):1667-76. doi: 10.1128/IAI.70.4.1667-1676.2002. Infect Immun. 2002. PMID: 11895928 Free PMC article. Review. No abstract available.
-
Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems.Infect Immun. 2001 Sep;69(9):5626-34. doi: 10.1128/IAI.69.9.5626-5634.2001. Infect Immun. 2001. PMID: 11500438 Free PMC article.
-
Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells.Infect Immun. 1999 Dec;67(12):6394-402. doi: 10.1128/IAI.67.12.6394-6402.1999. Infect Immun. 1999. PMID: 10569755 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
